| CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection, and specific antitumor memory L Mortara, P Castellani, R Meazza, G Tosi, A De Lerma Barbaro, ... Clinical cancer research 12 (11), 3435-3443, 2006 | 792 | 2006 |
| Macrophage polarization in chronic inflammatory diseases: killers or builders? L Parisi, E Gini, D Baci, M Tremolati, M Fanuli, B Bassani, G Farronato, ... Journal of immunology research 2018, 2018 | 454 | 2018 |
| Contribution to tumor angiogenesis from innate immune cells within the tumor microenvironment: implications for immunotherapy A Albini, A Bruno, DM Noonan, L Mortara Frontiers in immunology 9, 527, 2018 | 364 | 2018 |
| Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS C Kornfeld, MJY Ploquin, I Pandrea, A Faye, R Onanga, C Apetrei, ... The Journal of clinical investigation 115 (4), 1082-1091, 2005 | 327 | 2005 |
| Inflammation, inflammatory cells and angiogenesis: decisions and indecisions DM Noonan, A De Lerma Barbaro, N Vannini, L Mortara, A Albini Cancer and Metastasis Reviews 27, 31-40, 2008 | 302 | 2008 |
| The proangiogenic phenotype of natural killer cells in patients with non-small cell lung cancer A Bruno, C Focaccetti, A Pagani, AS Imperatori, M Spagnoletti, N Rotolo, ... Neoplasia 15 (2), 133-IN7, 2013 | 223 | 2013 |
| Myeloid derived suppressor cells interactions with natural killer cells and pro-angiogenic activities: roles in tumor progression A Bruno, L Mortara, D Baci, DM Noonan, A Albini Frontiers in immunology 10, 454180, 2019 | 168 | 2019 |
| CD56brightCD16− NK cells produce adenosine through a CD38-mediated pathway and act as regulatory cells inhibiting autologous CD4+ T cell proliferation F Morandi, AL Horenstein, A Chillemi, V Quarona, S Chiesa, A Imperatori, ... The Journal of Immunology 195 (3), 965-972, 2015 | 147 | 2015 |
| Tat-vaccinated macaques do not control simian immunodeficiency virus SIVmac239 replication TM Allen, L Mortara, BR Mothé, M Liebl, P Jing, B Calore, M Piekarczyk, ... Journal of virology 76 (8), 4108-4112, 2002 | 142 | 2002 |
| Natural killer cells as key players of tumor progression and angiogenesis: old and novel tools to divert their pro-tumor activities into potent anti-tumor effects B Bassani, D Baci, M Gallazzi, A Poggi, A Bruno, L Mortara Cancers 11 (4), 461, 2019 | 141 | 2019 |
| Dendritic cell editing by activated natural killer cells results in a more protective cancer-specific immune response B Morandi, L Mortara, L Chiossone, RS Accolla, MC Mingari, L Moretta, ... PloS one 7 (6), e39170, 2012 | 140 | 2012 |
| Orchestration of angiogenesis by immune cells A Bruno, A Pagani, L Pulze, A Albini, K Dallaglio, DM Noonan, L Mortara Frontiers in oncology 4, 131, 2014 | 125 | 2014 |
| Anti-cancer therapies employing IL-2 cytokine tumor targeting: contribution of innate, adaptive and immunosuppressive cells in the anti-tumor efficacy L Mortara, E Balza, A Bruno, A Poggi, P Orecchia, B Carnemolla Frontiers in Immunology 9, 424754, 2018 | 118 | 2018 |
| Plasmacytoid dendritic cell dynamics and alpha interferon production during Simian immunodeficiency virus infection with a nonpathogenic outcome OM Diop, MJY Ploquin, L Mortara, A Faye, B Jacquelin, D Kunkel, ... Journal of Virology 82 (11), 5145-5152, 2008 | 118 | 2008 |
| CTLA-4 is expressed by human monocyte—derived dendritic cells and regulates their functions S Laurent, P Carrega, D Saverino, P Piccioli, M Camoriano, A Morabito, ... Human immunology 71 (10), 934-941, 2010 | 114 | 2010 |
| Selection of virus variants and emergence of virus escape mutants after immunization with an epitope vaccine L Mortara, F Letourneur, H Gras-masse, A Venet, JG Guillet, ... Journal of virology 72 (2), 1403-1410, 1998 | 114 | 1998 |
| The ovarian cancer tumor immune microenvironment (TIME) as target for therapy: a focus on innate immunity cells as therapeutic effectors D Baci, A Bosi, M Gallazzi, M Rizzi, DM Noonan, A Poggi, A Bruno, ... International journal of molecular sciences 21 (9), 3125, 2020 | 108 | 2020 |
| Targeted Delivery of Tumor Necrosis Factor-α to Tumor Vessels Induces a Therapeutic T Cell–Mediated Immune Response that Protects the Host Against Syngeneic Tumors of Different … E Balza, L Mortara, F Sassi, S Monteghirfo, B Carnemolla, P Castellani, ... Clinical cancer research 12 (8), 2575-2582, 2006 | 104 | 2006 |
| Down syndrome, autoimmunity and T regulatory cells FP Pellegrini, M Marinoni, V Frangione, A Tedeschi, V Gandini, F Ciglia, ... Clinical & Experimental Immunology 169 (3), 238-243, 2012 | 98 | 2012 |
| Angiogenin and the MMP9‐TIMP2 axis are up‐regulated in proangiogenic, decidual NK‐like cells from patients with colorectal cancer A Bruno, B Bassani, DG D'Urso, I Pitaku, E Cassinotti, G Pelosi, L Boni, ... The FASEB Journal 32 (10), 5365-5377, 2018 | 92 | 2018 |
